Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Pfizer | INDUSTRY |
| American Cancer Society, Inc. | OTHER |
Not provided
Not provided
Not provided
Not provided
Black cancer patients tend to have worse outcomes than White cancer patients. Some of this disparity may be due to comorbidities. The purpose of this study is to improve management of co-morbidities among cancer patients in order to improve cancer outcomes and improve health equity.
Comorbidities such as diabetes and hypertension can complicate cancer treatment or can make it difficult to reach optimal health after treatment. This study will offer additional support and tools to manage cancer patient's health needs. First, the study will use a mobile health application, managed by a company called Welldoc, to monitor patient progress in real time and to provide ongoing guidance. Second, the study will connect patients with a Community Health Worker who will speak with them weekly to discuss self-care information, including medical scheduling or appointment needs, and assist with daily self-monitoring of blood pressure and/or blood glucose monitoring. Lastly, an oncology nurse will monitor reported health and triage any medical needs and whether additional medical care is needed.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention | Experimental | Will receive mHealth support for comorbidity and support from a Community Health Worker by phone |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Support | Behavioral | Community Health Workers will conduct weekly phone calls to monitor blood pressure or blood glucose, to check in on patient need for social, practical or emotional supports, and to encourage healthy lifestyle modification. Participants will also have access to a mobile app to support chronic disease management (Either diabetes or hypertension). |
| Measure | Description | Time Frame |
|---|---|---|
| Feasibility of study protocol | Accrual of >50 patients into the study | Study recruitment period will be approximately 12 months |
| Feasibility of an active management strategy for comorbidities | >80% recording blood pressure and/or blood glucose 3+ times per week | Study duration will be 6 months for prostate cancer patients and duration of treatment plus one month for breast cancer patients (approximately 7 months) |
| Feasibility of an active management strategy for comorbidities | >80% completion of weekly phone calls with community health workers | Study duration will be 6 months for prostate cancer patients and duration of treatment plus one month for breast cancer patients (approximately 7 months) |
| Measure | Description | Time Frame |
|---|---|---|
| Provider perspectives on acceptability of active management of comorbidities | >80% reporting agree to completely agree on the scale: Acceptability of Intervention Measure (FIM) measure. | Beginning and end of study (approximately 18 months) |
| Measure | Description | Time Frame |
|---|---|---|
| Preliminary changes in self-efficacy | PROMIS Self-Efficacy for Managing Chronic Conditions | To be assess at baseline and end of study; approximately 6-7 months per participant |
| Preliminary changes in social support |
Inclusion Criteria:
Exclusion Criteria:
- Unwilling to participate in a 6-month study
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Hannah Arem, PhD | Medstar Health Research Institute | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| MedStar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 39028275 | Derived | Schubel L, Mete M, Fong A, Boxley C, Barac A, Gallagher C, Magee MF, Arem H. Understanding Perceptions of Care Coordination and Chronic Illness Management among Black Breast and Prostate Cancer Survivors and Providers: Findings from a Quality Improvement Study. J Ambul Care Manage. 2024 Oct-Dec 01;47(4):228-238. doi: 10.1097/JAC.0000000000000505. Epub 2024 Aug 23. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| D003920 | Diabetes Mellitus |
| D006973 | Hypertension |
| D011471 | Prostatic Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D010166 | Palliative Care |
| ID | Term |
|---|---|
| D005791 | Patient Care |
| D013812 | Therapeutics |
| D006296 | Health Services |
| D005159 | Health Care Facilities Workforce and Services |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
PROMIS Social Support
| To be assess at baseline and end of study; approximately 6-7 months per participant |
| D017437 |
| Skin and Connective Tissue Diseases |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D005834 | Genital Neoplasms, Male |
| D014565 | Urogenital Neoplasms |
| D005832 | Genital Diseases, Male |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D011469 | Prostatic Diseases |
| D052801 | Male Urogenital Diseases |